WHEC TV speaks with Center for Autism and Related Disorders about the effects of the New York law that now requires insurance companies to cover the cost of autism therapy.
Categories
Subscribe
Archive
-
Recent Posts
Resources
- Autism Speaks - www.autismspeaks.org
- ActToday! -
www.act-today.org - Autism Live -
www.autism-live.com - The A-Word -
www.youtube.com - Mission Possible -
portraits-of-hope.centerforautism.com - Inspire -
www.inspire.com
CARD and Lineagen Offer FirstStepDx® Genetic Testing and Counseling for Children on the Autism Spectrum
Center for Autism and Related Disorders (CARD) and Lineagen, Inc. today announced the launch of a new clinical partnership to offer Lineagen’s FirstStepDx® genetic test to patients and their families. FirstStepDx is a whole-genome genetic test customized with validated, novel proprietary genetic variants associated with ASDs. Under the terms of the partnership agreement, FirstStepDx, integrated with a pre-and post-test genetic counseling service and personalized reporting, will be offered to patients receiving treatment in CARD’s innovative Skills® program. The program is the first of its kind, designed to fully meet current clinical guidelines that recommend chromosomal microarray analysis as a first-line genetic test as part of a comprehensive diagnostic evaluation of individuals with ASDs.